CONDENSED CONSOLIDATED STATEMENTS OF COMMON STOCK AND STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2022	$ 103,407	$ 3	$ 302,202	$ (197,794)	$ (1,004)
Beginning balance, shares at Dec. 31, 2022		30,764,160
Stock-based compensation expense	1,213		1,213
Issuance of equity in exchange for compensation	302		302
Issuance of equity in exchange for compensation, Shares		208,510
Surrender of shares for tax withholding	(76)		(76)
Surrender of shares for tax withholding, Shares		(50,343)
Vesting of restricted stock shares, shares		49,014
Unrealized gain on marketable securities	181				181
Net Income (Loss)	(10,177)			(10,177)
Ending balance at Mar. 31, 2023	94,850	$ 3	303,641	(207,971)	(823)
Ending balance, shares at Mar. 31, 2023		30,971,341
Beginning balance at Dec. 31, 2022	103,407	$ 3	302,202	(197,794)	(1,004)
Beginning balance, shares at Dec. 31, 2022		30,764,160
Unrealized gain on marketable securities	455
Net Income (Loss)	(19,563)
Ending balance at Jun. 30, 2023	79,201	$ 3	297,104	(217,357)	(549)
Ending balance, shares at Jun. 30, 2023		26,583,819
Beginning balance at Mar. 31, 2023	94,850	$ 3	303,641	(207,971)	(823)
Beginning balance, shares at Mar. 31, 2023		30,971,341
Stock-based compensation expense	1,095		1,095
Employee stock purchase plan expense	31		31
Employee stock purchase plan expense, Shares		25,964
Purchase agreement, net of issuance costs and excise tax	(7,663)		(7,663)
Purchase agreement, net of issuance costs and excise tax, Shares		(4,454,248)
Vesting of restricted stock shares, shares		40,762
Unrealized gain on marketable securities	274				274
Net Income (Loss)	(9,386)			(9,386)
Ending balance at Jun. 30, 2023	79,201	$ 3	297,104	(217,357)	(549)
Ending balance, shares at Jun. 30, 2023		26,583,819
Beginning balance at Dec. 31, 2023	64,895	$ 3	296,996	(231,895)	(209)
Beginning balance, shares at Dec. 31, 2023		25,030,188
Stock-based compensation expense	1,216		1,216
Issuance of equity in exchange for compensation	293		293
Surrender of shares for tax withholding	(10)		(10)
Surrender of shares for tax withholding, Shares		(12,361)
Vesting of restricted stock shares, shares		56,131
Unrealized gain on marketable securities	72				72
Net Income (Loss)	(7,992)			(7,992)
Ending balance at Mar. 31, 2024	58,474	$ 3	298,495	(239,887)	(137)
Ending balance, shares at Mar. 31, 2024		25,073,958
Beginning balance at Dec. 31, 2023	64,895	$ 3	296,996	(231,895)	(209)
Beginning balance, shares at Dec. 31, 2023		25,030,188
Unrealized gain on marketable securities	116
Net Income (Loss)	(15,134)
Ending balance at Jun. 30, 2024	52,192	$ 3	299,311	(247,029)	(93)
Ending balance, shares at Jun. 30, 2024		25,124,333
Beginning balance at Mar. 31, 2024	58,474	$ 3	298,495	(239,887)	(137)
Beginning balance, shares at Mar. 31, 2024		25,073,958
Stock-based compensation expense	795		795
Employee stock purchase plan expense	21		21
Employee stock purchase plan expense, Shares		43,375
Vesting of restricted stock shares, shares		7,000
Unrealized gain on marketable securities	44				44
Net Income (Loss)	(7,142)			(7,142)
Ending balance at Jun. 30, 2024	$ 52,192	$ 3	$ 299,311	$ (247,029)	$ (93)
Ending balance, shares at Jun. 30, 2024		25,124,333